Article
Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency.
The Journal of clinical endocrinology and metabolism - 1 May 1999
Nordenström A, Thilén A, Hagenfeldt L, Larsson A, Wedell A
Abstract excerpt
To evaluate genotyping as a diagnostic complement to neonatal screening for congenital adrenal hyperplasia, 91 children who had been diagnosed with this condition between 1986 and 1997 were analyzed for mutations in the steroid 21-hydroxylase gene. Screening levels of 17-hydroxyprogesterone were compared in patients representing different genotypes. Genotyping was performed using allele-specific PCR, the patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
